← The Wire
NTRANasdaq
Natera, Inc.
Services-Medical Laboratories · DE · CIK 1604821
Natera applies proprietary molecular and bioinformatics technology to change disease management worldwide through genetic testing
red 8-K · 90d🔥 High media attention
$30.37B
Market cap
$272.31
Last close
+4.0%
1D
+19.0%
5D
1.8M
Volume
Price · last 39 sessions+28.7%
May 4L $186.36 · H $272.31Jun 29
78
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
8-K/AExecutive ChangeJun 16, 20268-KExecutive Change · Shareholder VoteJun 16, 20268-KExecutive ChangeJun 5, 202610-Q10-QMay 8, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KExecutive ChangeApr 1, 202610-K10-KFeb 27, 20268-KResults of OperationsFeb 26, 20268-KResults of OperationsJan 12, 20268-KEquity Issuance · Company UpdateDec 5, 202510-Q10-QNov 7, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 8, 20258-KResults of OperationsAug 7, 20258-KExecutive Change · Shareholder VoteJun 18, 202510-Q10-QMay 9, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 20258-KExecutive ChangeMar 12, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 27, 20258-KResults of OperationsJan 13, 20258-KExecutive ChangeDec 6, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QAug 9, 20248-KResults of OperationsAug 8, 20248-KCompany UpdateJul 22, 20248-KExecutive Change · Shareholder VoteJun 18, 2024DEFA14ADEFA14AJun 5, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 24, 2024DEF 14ADEF 14AApr 24, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 28, 2024SC 13GSC 13GJan 31, 20248-KCompany UpdateJan 22, 20248-KResults of OperationsJan 9, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 8, 20238-KMaterial Agreement · Company UpdateSep 7, 2023424B5424B5Sep 7, 202310-Q10-QAug 4, 20238-KResults of OperationsAug 3, 20238-KShareholder VoteJun 15, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 9, 20238-KExecutive ChangeApr 21, 2023DEFA14ADEFA14AApr 20, 2023DEF 14ADEF 14AApr 20, 20238-KReg FD DisclosureMar 13, 202310-K10-KMar 1, 20238-KResults of OperationsFeb 28, 20238-KExecutive ChangeFeb 23, 2023SC 13GSC 13GFeb 3, 20238-KMaterial Agreement · Company UpdateNov 16, 2022424B5424B5Nov 16, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 8, 20228-KExecutive ChangeAug 15, 202210-Q10-QAug 5, 20228-KResults of OperationsAug 4, 2022SC 13GSC 13GJun 9, 20228-KShareholder VoteJun 1, 202210-Q10-QMay 6, 20228-KResults of OperationsMay 5, 20228-KExecutive ChangeApr 15, 2022DEFA14ADEFA14AApr 13, 2022DEF 14ADEF 14AApr 13, 20228-KExecutive ChangeMar 14, 202210-K10-KFeb 25, 20228-KResults of OperationsFeb 24, 2022SC 13GFILING NATERA, INC.Jan 24, 202210-Q10-QNov 5, 2021
Insider Activity
In the 90 days to Mar 20, 2026: 8 sold $123.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 371 | $200.97 | $75K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 280 | $200.90 | $56K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 239 | $198.85 | $48K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 235 | $199.88 | $47K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 235 | $198.49 | $47K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 140 | $199.82 | $28K |
| Mar 18, 2026 | Sheena JonathanDirector,Other | Sell | 1,814 | $198.65 | $360K |
| Mar 18, 2026 | Sheena JonathanDirector,Other | Sell | 956 | $197.84 | $189K |
| Mar 18, 2026 | Sheena JonathanDirector,Other | Sell | 300 | $196.27 | $59K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 24,814 | $196.23 | $4.9M |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 16,457 | $197.22 | $3.2M |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 4,875 | $195.42 | $953K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 2,300 | $194.17 | $447K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 900 | $192.43 | $173K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 300 | $190.68 | $57K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 254 | $198.02 | $50K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 100 | $190.07 | $19K |
| Mar 13, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 21,504 | $189.50 | $4.1M |
| Mar 13, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 21,476 | $188.54 | $4.0M |
| Mar 13, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 17,037 | $187.63 | $3.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 3 reputable articles.
Investor's Business DailyMedical Services Name Tests For Colon Cancer. Natera Stock Hits A High.19h agoInvestor's Business DailyThis Medtech Stock Just Flashed A Buy Signal; Here's Why5d agoBarron's5 Healthcare Stocks That the AI Crowd Is Overlooking24d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance